Lisa M Parker (Lisa Parker)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Systematic Review

Cross Sectional

Respiratory Syndrome Coronavirus

Top Venues

BMJ open science

International journal of health policy and management

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jack Wilkinson, Calvin Heal, George A Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Ginny Barbour, Nicholas J L Brown, John Carlisle, Michael Clarke, Patrick Dicker, Jo C Dumville, Andrew Grey, Steph Grohmann, Lyle Gurrin, Jill Alison Hayden, James Heathers, Kylie Elizabeth Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben-Willem J Mol, Neil E O'Connell, Lisa M Parker, Barbara K Redman, Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David Torgerson, Madelon van Wely, Rui Wang, Lisa A Bero, Jamie J Kirkham
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. BMJ open 14 (3) (2024)
Jack Wilkinson, Calvin Heal, George A Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Ginny Barbour, Nicholas J L Brown, John Carlisle, Michael Clarke, Patrick Dicker, Jo C Dumville, Andrew Grey, Steph Grohmann, Lyle Gurrin, Jill Alison Hayden, James Heathers, Kylie Elizabeth Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben-Willem J Mol, Neil E O'Connell, Lisa M Parker, Barbara K Redman, Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David Torgerson, Madelon van Wely, Rui Wang, Lisa A Bero, Jamie J Kirkham
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. BMJ open 14 (3) (2024)
Jack Wilkinson, Calvin Heal, George A Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Ginny Barbour, Nicholas J L Brown, John Carlisle, Michael Clarke, Patrick Dicker, Jo C Dumville, Andrew Grey, Steph Grohmann, Lyle Gurrin, Jill Alison Hayden, James Heathers, Kylie Elizabeth Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben-Willem J Mol, Neil E O'Connell, Lisa M Parker, Barbara K Redman, Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David Torgerson, Madelon van Wely, Rui Wang, Lisa A Bero, Jamie J Kirkham
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. BMJ open 14 (3) (2024)
Jack Wilkinson, Calvin Heal, George A Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Ginny Barbour, Nicholas J L Brown, John Carlisle, Michael Clarke, Patrick Dicker, Jo C Dumville, Andrew Grey, Steph Grohmann, Lyle Gurrin, Jill Alison Hayden, James Heathers, Kylie Elizabeth Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben-Willem J Mol, Neil E O'Connell, Lisa M Parker, Barbara K Redman, Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David Torgerson, Madelon van Wely, Rui Wang, Lisa A Bero, Jamie J Kirkham
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. BMJ open 14 (3) (2024)
Jack Wilkinson, Calvin Heal, George A Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Ginny Barbour, Nicholas J L Brown, John Carlisle, Michael Clarke, Patrick Dicker, Jo C Dumville, Andrew Grey, Steph Grohmann, Lyle Gurrin, Jill Alison Hayden, James Heathers, Kylie Elizabeth Hunter, Toby Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben-Willem J Mol, Neil E O'Connell, Lisa M Parker, Barbara K Redman, Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David Torgerson, Madelon van Wely, Rui Wang, Lisa A Bero, Jamie J Kirkham
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. BMJ open 14 (3) (2024)
Ashleigh Hooimeyer, Travis Lines, Janet Mirzaei, Preshita Pande, Sylviya Ganeshamoorthy, Alice Fabbri, Lisa M Parker, Adam G Dunn, Barbara J Mintzes
Conflict of Interest Policies at Australian Medical Schools. Internal medicine journal (2023)
Lisa M Parker, Quinn Grundy, Alice Fabbri, Barbara J Mintzes, Lisa A Bero
'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. BMJ open 11 (2) (2021)
Lisa A Bero, Lisa M Parker
Risky business? Pharmaceutical industry sponsorship of health consumer groups. Australian prescriber 44 (3) (2021)
Lisa M Parker, Jennifer A Byrne, Micah Goldwater, Nick Enfield
Misinformation: an empirical study with scientists and communicators during the COVID-19 pandemic. BMJ open science 5 (1) (2021)
Emily Aspasia Karanges, Conrad Nangla, Lisa M Parker, Alice Fabbri, Cynthia M Farquhar, Lisa A Bero
Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study. BMJ open 11 (9) (2021)
Lisa A Bero, Rosa Lawrence, Louis Leslie, Kellia Chiu, Sally McDonald, Matthew J Page, Quinn Grundy, Lisa M Parker, Stephanie Boughton, Jamie J Kirkham, Robin Featherstone
Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation. BMJ open 11 (7) (2021)
Ray Moynihan, Alice Fabbri, Lisa M Parker, Lisa Bero
Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. BMJ open 10 (5) (2020)
Nicholas Chartres, Quinn Grundy, Lisa M Parker, Lisa A Bero
"It's Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development. International journal of health policy and management 9 (8) (2020)
Lisa M Parker, Alexandra Bennett, Barbara Mintzes, Quinn Grundy, Alice Fabbri, Emily A Karanges, Lisa Bero
"There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence. British journal of clinical pharmacology 87 (5) (2020)
Lisa M Parker, Emily A Karanges, Lisa Bero
Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study. BMJ open 9 (2) (2019)
Lisa M Parker, Alice Fabbri, Quinn Grundy, Barbara J Mintzes, Lisa A Bero
"Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ (Clinical research ed.) 367 (2019)
Lisa M Parker, Tanya Karliychuk, Donna Gillies, Barbara Mintzes, Melissa Raven, Quinn Grundy
A health app developer's guide to law and policy: a multi-sector policy analysis. BMC medical informatics and decision making 17 (1) (2017)